149 related articles for article (PubMed ID: 19351185)
1. Preparation of mammalian expression vectors incorporating site-specifically platinated-DNA lesions.
Ang WH; Brown WW; Lippard SJ
Bioconjug Chem; 2009 May; 20(5):1058-63. PubMed ID: 19351185
[TBL] [Abstract][Full Text] [Related]
2. Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
Ang WH; Myint M; Lippard SJ
J Am Chem Soc; 2010 Jun; 132(21):7429-35. PubMed ID: 20443565
[TBL] [Abstract][Full Text] [Related]
3. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
Zhu G; Myint M; Ang WH; Song L; Lippard SJ
Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
[TBL] [Abstract][Full Text] [Related]
4. Protein interactions with platinum-DNA adducts: from structure to function.
Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
[TBL] [Abstract][Full Text] [Related]
5. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
[TBL] [Abstract][Full Text] [Related]
6. 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex.
Spingler B; Whittington DA; Lippard SJ
Inorg Chem; 2001 Oct; 40(22):5596-602. PubMed ID: 11599959
[TBL] [Abstract][Full Text] [Related]
7. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
Pang SK; So WK; Ho YP; Au-Yeung CF
Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
Malina J; Natile G; Brabec V
Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nuclear factor kappaB proteins-platinated DNA interactions correlates with cytotoxic effectiveness of the platinum complexes.
Brabec V; Kasparkova J; Kostrhunova H; Farrell NP
Sci Rep; 2016 Aug; 6():28474. PubMed ID: 27574114
[TBL] [Abstract][Full Text] [Related]
10. Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome.
Naser LJ; Pinto AL; Lippard SJ; Essigmann JM
Biochemistry; 1988 Jun; 27(12):4357-67. PubMed ID: 3166983
[TBL] [Abstract][Full Text] [Related]
11. Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.
Zhu G; Chang P; Lippard SJ
Biochemistry; 2010 Jul; 49(29):6177-83. PubMed ID: 20550106
[TBL] [Abstract][Full Text] [Related]
12. Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies.
Kaspárková J; Mellish KJ; Qu Y; Brabec V; Farrell N
Biochemistry; 1996 Dec; 35(51):16705-13. PubMed ID: 8988007
[TBL] [Abstract][Full Text] [Related]
13. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent.
Baruah H; Wright MW; Bierbach U
Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895
[TBL] [Abstract][Full Text] [Related]
14. TOX4 and its binding partners recognize DNA adducts generated by platinum anticancer drugs.
Bounaix Morand du Puch C; Barbier E; Kraut A; Couté Y; Fuchs J; Buhot A; Livache T; Sève M; Favier A; Douki T; Gasparutto D; Sauvaigo S; Breton J
Arch Biochem Biophys; 2011 Mar; 507(2):296-303. PubMed ID: 21184731
[TBL] [Abstract][Full Text] [Related]
15. Use of novel plasmid constructs to demonstrate fludarabine triphosphate inhibition of nucleotide excision repair of a site-specific 1,2-d(GpG) intrastrand cisplatin adduct.
Li MJ; Yang LY
Int J Oncol; 1999 Dec; 15(6):1177-83. PubMed ID: 10568825
[TBL] [Abstract][Full Text] [Related]
16. Fast interstrand cross-linking of cisplatin-DNA monoadducts compared with intrastrand chelation: a kinetic study using hairpin-stabilized duplex oligonucleotides.
Monjardet-Bas V; Chottard JC; Kozelka J
Chemistry; 2002 Mar; 8(5):1144-50. PubMed ID: 11891902
[TBL] [Abstract][Full Text] [Related]
17. Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.
Wu Y; Bhattacharyya D; King CL; Baskerville-Abraham I; Huh SH; Boysen G; Swenberg JA; Temple B; Campbell SL; Chaney SG
Biochemistry; 2007 Jun; 46(22):6477-87. PubMed ID: 17497831
[TBL] [Abstract][Full Text] [Related]
18. Multiple states of stalled T7 RNA polymerase at DNA lesions generated by platinum anticancer agents.
Jung Y; Lippard SJ
J Biol Chem; 2003 Dec; 278(52):52084-92. PubMed ID: 14534300
[TBL] [Abstract][Full Text] [Related]
19. Platinum anti-cancer drugs: Free radical mechanism of Pt-DNA adduct formation and anti-neoplastic effect.
Fong CW
Free Radic Biol Med; 2016 Jun; 95():216-29. PubMed ID: 27012421
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA.
Guggenheim ER; Xu D; Zhang CX; Chang PV; Lippard SJ
Chembiochem; 2009 Jan; 10(1):141-57. PubMed ID: 19053130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]